Meeder Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.1K | Buy |
240
+143
| +147% | +$9.96K | ﹤0.01% | 621 |
|
|
2025
Q4 | $6.44K | Sell |
97
-1
| -1% | -$65 | ﹤0.01% | 751 |
|
|
2025
Q3 | $6.59K | Buy |
98
+6
| +7% | +$475 | ﹤0.01% | 623 |
|
|
2025
Q2 | $8.03K | Buy |
92
+12
| +15% | +$941 | ﹤0.01% | 655 |
|
|
2025
Q1 | $5.46K | Sell |
80
-36
| -31% | -$2.94K | ﹤0.01% | 750 |
|
|
2024
Q4 | $9.02K | Sell |
116
-8
| -6% | -$592 | ﹤0.01% | 724 |
|
|
2024
Q3 | $8.31K | Buy |
124
+13
| +12% | +$1.07K | ﹤0.01% | 654 |
|
|
2024
Q2 | $12.6K | Buy |
111
+31
| +39% | +$3.92K | ﹤0.01% | 602 |
|
|
2024
Q1 | $11.1K | Buy |
+80
| New | +$10.1K | ﹤0.01% | 533 |
|
|
2023
Q2 | – | Sell |
-11,374
| Closed | -$1.32M | – | 530 |
|
|
2023
Q1 | $1.32M | Buy |
11,374
+10,531
| +1,249% | +$1.18M | 0.11% | 150 |
|
|
2022
Q4 | $95.5K | Sell |
843
-11,599
| -93% | -$1.27M | 0.01% | 480 |
|
|
2022
Q3 | $1M | Buy |
12,442
+9,612
| +340% | +$814K | 0.06% | 246 |
|
|
2022
Q2 | $211K | Sell |
2,830
-838
| -23% | -$76.5K | 0.01% | 589 |
|
|
2022
Q1 | $469K | Buy |
+3,668
| New | +$401K | 0.02% | 417 |
|
|
2021
Q4 | – | Sell |
-2,828
| Closed | -$387K | – | 1495 |
|
|
2021
Q3 | $387K | Buy |
2,828
+552
| +24% | +$69.6K | 0.02% | 525 |
|
|
2021
Q2 | $243K | Buy |
2,276
+468
| +26% | +$44.9K | 0.01% | 689 |
|
|
2021
Q1 | $162K | Buy |
1,808
+436
| +32% | +$40.9K | 0.01% | 789 |
|
|
2020
Q4 | $127K | Sell |
1,372
-1,172
| -46% | -$105K | 0.03% | 378 |
|
|
2020
Q3 | $263K | Sell |
2,544
-10,800
| -81% | -$1.13M | 0.02% | 539 |
|
|
2020
Q2 | $1.35M | Buy |
13,344
+420
| +3% | +$37.6K | 0.09% | 200 |
|
|
2020
Q1 | $870K | Sell |
12,924
-3,992
| -24% | -$248K | 0.07% | 231 |
|
|
2019
Q4 | $924K | Buy |
16,916
+16,792
| +13,542% | +$796K | 0.06% | 269 |
|
|
2019
Q3 | $5K | Sell |
124
-80
| -39% | -$3.11K | ﹤0.01% | 1753 |
|
|
2019
Q2 | $8K | Sell |
204
-1,620
| -89% | -$50.9K | ﹤0.01% | 1517 |
|
|
2019
Q1 | $54K | Sell |
1,824
-7,244
| -80% | -$255K | ﹤0.01% | 858 |
|
|
2018
Q4 | $272K | Buy |
9,068
+8,668
| +2,167% | +$275K | 0.02% | 436 |
|
|
2018
Q3 | $14K | Buy |
+400
| New | +$12.4K | ﹤0.01% | 1094 |
|
|
2016
Q4 | – | Sell |
-540
| Closed | -$12K | – | 1000 |
|
|
2016
Q3 | $12K | Sell |
540
-1,356
| -72% | -$30.2K | ﹤0.01% | 704 |
|
|
2016
Q2 | $38K | Sell |
1,896
-5,044
| -73% | -$85.9K | ﹤0.01% | 745 |
|
|
2016
Q1 | $118K | Sell |
6,940
-37,928
| -85% | -$634K | 0.01% | 674 |
|
|
2015
Q4 | $919K | Buy |
44,868
+25,924
| +137% | +$539K | 0.08% | 200 |
|
|
2015
Q3 | $406K | Buy |
+18,944
| New | +$423K | 0.04% | 424 |
|
Other funds holding DXCM
VCM
VPM
Meeder Asset Management's DXCM Position: Q1 2026 in Review
Meeder Asset Management increased its DexCom (DXCM) stake by 147% in Q1 2026, buying an estimated $9.96K and bringing the position to 240 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #621.
Meeder Asset Management first reported a position in DXCM in Q3 2015 and has held it in 32 quarters since. The position peaked at $1.35M in Q2 2020. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Meeder Asset Management held 240 shares of DexCom worth $15.1K as of Q1 2026.
- Meeder Asset Management bought 143 DexCom shares in Q1 2026, an estimated $9.96K.
- DexCom made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #621 holding.
- Meeder Asset Management first reported a position in DexCom in Q3 2015 and has held it in 32 quarters since.
- Meeder Asset Management's DexCom position peaked at $1.35M in Q2 2020.
- 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.